Crossref
Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy
ACTA Pharmaceutica Sciencia · 2026 · 64 (3) · 425
DOI: 10.23893/1307-2080.aps64022 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2026. Verfasst von Asmaa M. Rashid und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rashid, A. M., Suza, H. M., Khafeef, H. K., Alwiswasi, N. N., Yehia, M., & Al-zheery, W. H. (2026). Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy. ACTA Pharmaceutica Sciencia, 64(3), 425. https://doi.org/10.23893/1307-2080.aps64022
Vancouver
Rashid AM, Suza HM, Khafeef HK, Alwiswasi NN, Yehia M, Al-zheery WH. Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy. ACTA Pharmaceutica Sciencia. 2026;64(3):425. doi:10.23893/1307-2080.aps64022
BibTeX
@article{Rashid2026,
author = {Rashid, Asmaa M. and Suza, Hiba M. and Khafeef, Hawraa K. and Alwiswasi, Noor Najim and Yehia, Muna and Al-zheery, Worood Hameed},
title = {Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy},
journal = {ACTA Pharmaceutica Sciencia},
year = {2026},
volume = {64},
number = {3},
pages = {425},
doi = {10.23893/1307-2080.aps64022}
}
EUVIMED